BeiGene (BGNE)
(Delayed Data from NSDQ)
$152.71 USD
-3.46 (-2.22%)
Updated May 24, 2024 04:00 PM ET
After-Market: $152.44 -0.27 (-0.18%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth B Momentum F VGM
Brokerage Reports
BeiGene, Ltd. [BGNE]
Reports for Purchase
Showing records 1 - 12 ( 12 total )
Company: BeiGene, Ltd.
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for BGNE 112123
Provider: Stock Traders Daily
Analyst: Research Department
Company: BeiGene, Ltd.
Industry: Medical - Biomedical and Genetics
Weekly Retail Sales Tracker for Hem. Malignancies - Week Ended July 7
Provider: Wedbush Securities Inc.
Analyst: NIERENGARTEN D
Company: BeiGene, Ltd.
Industry: Medical - Biomedical and Genetics
Weekly Retail Sales Tracker for Hem. Malignancies - Week Ended March 11.
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: BeiGene, Ltd.
Industry: Medical - Biomedical and Genetics
Company: BeiGene, Ltd.
Industry: Medical - Biomedical and Genetics
Weekly Retail Sales Tracker for Hem. Malignancies - Week Ended September 11
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: BeiGene, Ltd.
Industry: Medical - Biomedical and Genetics
Weekly Retail Sales Tracker for Hem. Malignancies - Week Ended May 15
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: BeiGene, Ltd.
Industry: Medical - Biomedical and Genetics
Weekly Retail Sales Tracker for Hem. Malignancies - Week Ended May 8
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: BeiGene, Ltd.
Industry: Medical - Biomedical and Genetics
Weekly Retail Sales Tracker for Hem. Malignancies - Week Ended May 1
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: BeiGene, Ltd.
Industry: Medical - Biomedical and Genetics
Time to Bring the B (Cell) Team into the COVID Wars
Provider: WEDBUSH SECURITIES INC.
Analyst: DRISCOLL R
Company: BeiGene, Ltd.
Industry: Medical - Biomedical and Genetics
Weekly Retail Sales Tracker for Hem. Malignancies - Week Ended March 13
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: BeiGene, Ltd.
Industry: Medical - Biomedical and Genetics
Weekly Retail Sales Tracker for Hem. Malignancies
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: BeiGene, Ltd.
Industry: Medical - Biomedical and Genetics
Weekly Retail Sales Tracker for Hem. Malignancies
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
|